Day One Biopharmaceuticals completes Mersana acquisition Jan 6, 2026 09:02AM
Day One Completes Acquisition of Mersana Therapeutics Jan 6, 2026 09:02AM
Day One Biopharmaceuticals to acquire Mersana Therapeutics for $285M Nov 13, 2025 06:00AM
Day One Biopharmaceuticals to Acquire Mersana Therapeutics Nov 13, 2025 06:00AM
Mersana Therapeutics to Present at Upcoming Investor Conferences May 20, 2025 08:00AM


Feb 25, 2025 08:00AM Mersana Therapeutics to Present at Upcoming Investor Conferences
May 22, 2024 08:00AM Mersana Therapeutics to Present at Upcoming Investor Conferences
Feb 27, 2024 08:01AM Mersana Therapeutics to Present at Upcoming Investor Conferences
May 24, 2023 08:00AM Mersana Therapeutics to Present at Upcoming Investor Conferences
May 26, 2022 08:00AM Mersana Therapeutics to Present at Upcoming Investor Conferences
Mar 2, 2022 08:00AM Mersana Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
Feb 28, 2022 06:00AM Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Feb 26, 2021 06:00AM Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Jan 5, 2021 12:49PM Mersana (MRSN) Defended at Cowen
Jun 2, 2020 05:24PM Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 29, 2020 05:54AM Mersana Therapeutics (MRSN) Prices 8M Share Common Offering at $19/Sh
May 28, 2020 11:24PM Mersana Therapeutics Announces Pricing of Public Offering of Common Stock
May 28, 2020 06:03AM Mersana Therapeutics (MRNS) to Offer 5M Shares
May 28, 2020 06:00AM Mersana Therapeutics Announces Proposed Public Offering of Common Stock
Apr 7, 2020 10:07PM Mersana Therapeutics Raises $65 Million in Gross Proceeds Through its At-the-Market Facility
Feb 28, 2020 06:00AM Mersana Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Updates
Feb 18, 2020 08:00AM Mersana Therapeutics to Present at Upcoming Investor Conferences
Mar 8, 2019 06:00AM  Mersana Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates
Mar 8, 2019 06:00AM  Mersana Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates
Mar 6, 2019 08:00AM Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference
Mar 6, 2019 08:00AM Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference
Jul 19, 2018 11:11AM Mersana Therapeutics (MRSN) Partial Clinical Hold on XMT-1522 is Disappointing - Cowen
Feb 7, 2018 08:00AM Mersana Therapeutics to Present at Upcoming Investor Conferences
Jul 24, 2017 05:46AM Cowen Starts Mersana (MRSN) at Outperform
Jun 28, 2017 10:56AM Mersana Therapeutics (MRSN) IPO Opens Modestly Lower